{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:10:31Z","timestamp":1760188231107},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2003,9,1]]},"DOI":"10.1038\/sj.leu.2403037","type":"journal-article","created":{"date-parts":[[2003,9,11]],"date-time":"2003-09-11T14:47:26Z","timestamp":1063291646000},"page":"1901-1902","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Myelodysplastic features developing in Philadephia-negative cells during imatinib mesylate therapy for CML: report of a new case"],"prefix":"10.1038","volume":"17","author":[{"given":"M J","family":"Mozziconacci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Caill\u00e8res","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Maurice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Vey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Sainty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Blaise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Lafage-Pochitaloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,9,10]]},"reference":[{"key":"BF2403037_CR1","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/sj.leu.2402842","volume":"17","author":"YL Chee","year":"2003","unstructured":"Chee YL, Vickers MA, Stevenson D, Holyoake TL, Culligan DJ . Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones. Leukemia 2003; 17: 634\u2013635.","journal-title":"Leukemia"},{"key":"BF2403037_CR2","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/sj.leu.2402634","volume":"16","author":"MK Andersen","year":"2002","unstructured":"Andersen MK, Pedersen-Bjergaard J, Kjeldsen L, Dufva IH, Br\u00f8ndum-Nielsen K . Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8. Leukemia 2002; 16: 1390\u20131395.","journal-title":"Leukemia"},{"key":"BF2403037_CR3","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood.V95.11.3273","volume":"95","author":"J Pedersen-Bjergaard","year":"2000","unstructured":"Pedersen-Bjergaard J, Andersen MK, Christiansen DH . Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation. Blood 2000; 95: 3273\u20133279.","journal-title":"Blood"},{"key":"BF2403037_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/sj.leu.2400642","volume":"11","author":"L Fayad","year":"1997","unstructured":"Fayad L, Kantarjian H, O'Brien S, Seong D, Albitar M, Keating M et al. Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases. Leukemia 1997; 11: 767\u2013771.","journal-title":"Leukemia"},{"key":"BF2403037_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0925-5710(96)00469-0","volume":"64","author":"T Izumi","year":"1996","unstructured":"Izumi T, Imagawa S, Hatake K, Miura Y, Arimaya T, Inazawa J et al. Philadelphia chromosome-negative cells with trisomy after busulfan and interferon treatment of Ph1-positive chronic myelogenous leukemia. Int J Hematol 1996; 64: 73\u201377.","journal-title":"Int J Hematol"},{"key":"BF2403037_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/sj.leu.2402848","volume":"17","author":"ME O'Dwyer","year":"2003","unstructured":"O'Dwyer ME, Gatter KM, Loriaux M, Druker BJ, Olson SB, Magenis RE et al. Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate. Leukemia 2003; 17: 481\u2013487.","journal-title":"Leukemia"},{"key":"BF2403037_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/sj.leu.2402791","volume":"17","author":"P Meeus","year":"2003","unstructured":"Meeus P, Demuynck H, Martiat Ph, Michaux L, Wouters E, Hagemeijer A . Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with imatinib. Leukemia 2003; 17: 465\u2013467.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403037","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:57:56Z","timestamp":1648778276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,1]]},"references-count":7,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9,1]]}},"alternative-id":["BF2403037"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403037","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,1]]},"assertion":[{"value":"3 April 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}